IMR Press / CEOG / Volume 38 / Issue 2 / pii/1630488781979-1222507981

Clinical and Experimental Obstetrics & Gynecology (CEOG) is published by IMR Press from Volume 46 Issue 1 (2019). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with S.O.G.

Open Access Original Research
Seroprevalence of other antibodies (herpes, CMV, rubella, varicella, hepatitis B and C, syphilis, chlamydia, mumps, toxoplasmosis) in HIV-positive patients
Show Less
1 Department of Obstetrics and Gynaecology
2 Prenatal Diagnosis and Therapy Centre
3 Virology Unit, Department of Microbiology, College of Medicine, University of Lagos, Idi-Araba, Surulere/Lagos (Nigeria)
Clin. Exp. Obstet. Gynecol. 2011, 38(2), 172–174;
Published: 10 June 2011
Abstract

We attempted to determine the seropositivity of HIV-positive patients to other antibodies (herpes, CMV, rubella, varicella, hepatitis B, hepatitis C, syphilis, chlamydia, mumps, toxoplasmosis). The study was carried out at the Prenatal Diagnosis and Therapy Centre of a Tertiary Hospital in Lagos, Nigeria. A total of 70 patients (50 females and 20 males) attending the centre between June 1997 and December 2005 who were screened and found to be HIV-seropositive were further screened for herpes simplex IgG/IgM, CMV IgG/IgM, rubella IgG/IgM, varicella IgG/IgM, mumps IgG/IgM, toxoplasmosis IgG/IgM, chlamydia IgG/IgM, hepatitis B and hepatitis C IgG/IgM using ELISA kits and syphilis (THPA) using the HAE method. Our study showed that a large number of HIV-positive patients are carriers of other antibodies and should be screened for them before therapy.
Keywords
HIV
Co-infection
Antibodies
Seroprevalence
Prepregnancy class
Share
Back to top